Post-pandemic Era-Global Antimalarial Drug Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type

Report ID: 254465 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Antimalarial Drug Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Plasmodium Falciparum -Product Introduction and Major Manufacturers
      1.1.2 Plasmodium Vivax -Product Introduction and Major Manufacturers
      1.1.3 Plasmodium Malariae -Product Introduction and Major Manufacturers
      1.1.4 Plasmodium Ovale -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2019-2026)
    2.2 Regional Market Share in Terms of Revenue (2019-2026)
    2.3 Regional Market Share in Terms of Consumption (2019-2026)
3 Global Antimalarial Drug Market Assessment by Type
    3.1 Global Antimalarial Drug Production by Type (2015-2026)
    3.2 Global Antimalarial Drug Revenue by Type (2015-2026)
    3.3 North America Antimalarial Drug Production and Revenue by Type (2015-2026)
    3.4 Asia Antimalarial Drug Production and Revenue by Type (2015-2026)
    3.5 Europe Antimalarial Drug Production and Revenue by Type (2015-2026)
    3.6 Middle East & Africa Antimalarial Drug Production and Revenue by Type (2015-2026)
    3.7 South America Antimalarial Drug Production and Revenue by Type (2015-2026)

4 Global Antimalarial Drug Market Assessment by Application
    4.1 Historical & Forecast Global Antimalarial Drug Consumption, Different Application Field (2015-2026)
    4.2 Historical & Forecast North America Antimalarial Drug Consumption, Different Application Field (2015-2026)
    4.3 Historical & Forecast Asia Antimalarial Drug Consumption, Different Application Field (2015-2026)
    4.4 Historical & Forecast Europe Antimalarial Drug Consumption, Different Application Field (2015-2026)
    4.5 Historical & Forecast Middle East & Africa Antimalarial Drug Consumption, Different Application Field (2015-2026)
    4.6 Historical & Forecast South America Antimalarial Drug Consumption, Different Application Field (2015-2026)

5 North America
    5.1 US Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.2 Canada Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    5.3 Mexico Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
6 Asia
    6.1 China Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.2 Japan Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.3 India Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.4 Korea Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    6.5 Southeat Asia Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
7 Europe
    7.1 Germany Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.2 UK Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.3 France Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.4 Russia Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    7.5 Italy Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
8 Middle East and Africa
    8.1 Saudi Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.2 UAE Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.3 Egypt Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.4 Nigeria Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    8.5 South Africa Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
9 South America
    9.1 Brazil Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.2 Argentina Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
    9.3 Colombia Antimalarial Drug Capacity, Production, Consumption and Proportion of Products Sold (2015-2026)
10 Global Antimalarial Drug Average Price Trend
    10.1 Market Price for Each Type of Antimalarial Drug in North America (2015-2026)
    10.2 Market Price for Each Type of Antimalarial Drug in Asia (2015-2026)
    10.3 Market Price for Each Type of Antimalarial Drug in Europe (2015-2026)
    10.4 Market Price for Each Type of Antimalarial Drug in Middle East & Africa (2015-2026)
    10.5 Market Price for Each Type of Antimalarial Drug in South America (2015-2026)

11 Value Chain (Impact of COVID-19)
    11.1 Antimalarial Drug Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Antimalarial Drug Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Antimalarial Drug Competitive Analysis
     12.1 Pfizer
        12.1.1 Pfizer Company Profiles
        12.1.2 Pfizer Product Introduction
        12.1.3 Pfizer Antimalarial Drug Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 GlaxoSmithKline
        12.2.1 GlaxoSmithKline Company Profiles
        12.2.2 GlaxoSmithKline Product Introduction
        12.2.3 GlaxoSmithKline Antimalarial Drug Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Ranbaxy Laboratories
        12.3.1 Ranbaxy Laboratories Company Profiles
        12.3.2 Ranbaxy Laboratories Product Introduction
        12.3.3 Ranbaxy Laboratories Antimalarial Drug Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 Ipca Laboratories Ltd
        12.4.1 Ipca Laboratories Ltd Company Profiles
        12.4.2 Ipca Laboratories Ltd Product Introduction
        12.4.3 Ipca Laboratories Ltd Antimalarial Drug Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
     12.5 Bayer
        12.5.1 Zydus Cadila Company Profiles
        12.5.2 Zydus Cadila Product Introduction
        12.5.3 Zydus Cadila Antimalarial Drug Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Merck KGaA
        12.6.1 Merck KGaA Company Profiles
        12.6.2 Merck KGaA Product Introduction
        12.6.3 Merck KGaA Antimalarial Drug Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Novartis AG
        12.7.1 Novartis AG Company Profiles
        12.7.2 Novartis AG Product Introduction
        12.7.3 Novartis AG Antimalarial Drug Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 Alvizia Health Care
        12.8.1 Alvizia Health Care Company Profiles
        12.8.2 Alvizia Health Care Product Introduction
        12.8.3 Alvizia Health Care Antimalarial Drug Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
     12.9 Bayer
        12.9.1 Bayer Company Profiles
        12.9.2 Bayer Product Introduction
        12.9.3 Bayer Antimalarial Drug Production, Revenue (2015-2020)
        12.9.4 SWOT Analysis
     12.10 Roche
        12.10.1 Roche Company Profiles
        12.10.2 Roche Product Introduction
        12.10.3 Roche Antimalarial Drug Production, Revenue (2015-2020)
        12.10.4 SWOT Analysis
13 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Antimalarial Drug Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table Regional Market Share in Terms of Production (2019-2026)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2019-2026)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure Global Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Global Antimalarial Drug Production Market Share (%) by Type (2019 -2020)
    Table Global Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure Global Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Global Antimalarial Drug Revenue Market Share (%) by Type (2019-2020)
    Figure North America Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure North America Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure North America Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure North America Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Asia Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure Asia Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Asia Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure Asia Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Europe Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure Europe Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Europe Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure Europe Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Middle East & Africa Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure Middle East & Africa Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure Middle East & Africa Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Figure South America Antimalarial Drug Production (K Unit) by Type (2015-2026)
    Figure South America Antimalarial Drug Production (K Unit) and Growth Rate (2015-2026)
    Figure South America Antimalarial Drug Revenue (Million USD) by Type (2015-2026)
    Figure South America Antimalarial Drug Revenue (Million USD) and Growth Rate (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure North America Antimalarial Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure North America Antimalarial Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure Asia Antimalarial Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Asia Antimalarial Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure Europe Antimalarial Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Europe Antimalarial Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Antimalarial Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure Middle East & Africa Antimalarial Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Figure South America Antimalarial Drug Consumption (K Unit) and Growth Rate (2015-2026)
    Figure South America Antimalarial Drug Consumption Market Share (%) by Application (2015-2026)
    Table Historical & Forecast Antimalarial Drug Different Application Field Consumption (K Unit)
    Table US Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Antimalarial Drug Capacity (K Units), Production (K Units) and Consumption (K Units) (2015-2026) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in China
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in EU
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in USA
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in Japan
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in India
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Antimalarial Drug in South America
    Figure Value Chain Structure of Antimalarial Drug
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Antimalarial Drug
    Figure Cost Structure of Antimalarial Drug in 2020
    Table Distributors/Traders List
    Table Pfizer Profiles
    Table Pfizer Antimalarial Drug Product Introduction
    Figure Pfizer Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Pfizer SWOT Analysis
    Table GlaxoSmithKline Profiles
    Table GlaxoSmithKline Antimalarial Drug Product Introduction
    Figure GlaxoSmithKline Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure GlaxoSmithKline SWOT Analysis
    Table Ranbaxy Laboratories Profiles
    Table Ranbaxy Laboratories Antimalarial Drug Product Introduction
    Figure Ranbaxy Laboratories Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Ranbaxy Laboratories SWOT Analysis
    Table Ipca Laboratories Ltd Profiles
    Table Ipca Laboratories Ltd Antimalarial Drug Product Introduction
    Figure Ipca Laboratories Ltd Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Ipca Laboratories Ltd SWOT Analysis
    Table Zydus Cadila Profiles
    Table Zydus Cadila Antimalarial Drug Product Introduction
    Figure Zydus Cadila Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Zydus Cadila SWOT Analysis
    Table Merck KGaA Profiles
    Table Merck KGaA Antimalarial Drug Product Introduction
    Figure Merck KGaA Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Merck KGaA SWOT Analysis
    Table Novartis AG Profiles
    Table Novartis AG Antimalarial Drug Product Introduction
    Figure Novartis AG Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Novartis AG SWOT Analysis
    Table Alvizia Health Care Profiles
    Table Alvizia Health Care Antimalarial Drug Product Introduction
    Figure Alvizia Health Care Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Alvizia Health Care SWOT Analysis
    Table Bayer Profiles
    Table Bayer Antimalarial Drug Product Introduction
    Figure Bayer Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Bayer SWOT Analysis
    Table Roche Profiles
    Table Roche Antimalarial Drug Product Introduction
    Figure Roche Antimalarial Drug Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Antimalarial Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Antimalarial Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Antimalarial Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports